1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 3: 
Patient demographics and LV-LVM characteristics
No.(%)
Total56
Sex
 Male2850.0%
 Female2850.0%
Classification
 LM3766.1%
 LVM1933.9%
Architecture
 Macrocystic916.1%
 Microcystic1933.9%
 Mixed2850.0%
Lesion laterality
 Right1832.1%
 Left1628.6%
 Bilateral2239.3%
de Serres stage
 I (unilateral infrahyoid)11.8%
 II (unilateral suprahyoid)2748.2%
 III (unilateral suprahyoid and infrahyoid)814.3%
 IV (bilateral suprahyoid)916.1%
 V (bilateral suprahyoid and infrahyoid)1119.6%